Figure S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma

Figure S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma

<p>Increased T lymphocyte infiltration in the recurrent compared to the primary tumor. (A) CD3 immunohistochemical staining in the primary and recurrent tumor. (B) Three fields of view were selected and counted CD3+ T cells in both perivascular and peritumoral areas of the primary and recurren...

保存先:

書誌詳細
第一著者:	Jian Wang (15048011) (author)
その他の著者:	Tobias Weiss (15048014) (author), Marian C. Neidert (15048017) (author), Nora C. Toussaint (15048020) (author), Reza Naghavian (15048023) (author), Carla Sellés Moreno (15048026) (author), Magdalena Foege (15048029) (author), Paula Tomas Ojer (15048032) (author), Gioele Medici (15048035) (author), Ivan Jelcic (15048038) (author), Daniel Schulz (15048041) (author), Elisabeth Rushing (15048044) (author), Susanne Dettwiler (15048047) (author), Barbara Schrörs (15048050) (author), Joo Heon Shin (15048053) (author), Ron McKay (15048056) (author), Catherine J. Wu (14944480) (author), Andreas Lutterotti (15048059) (author), Mireia Sospedra (15048062) (author), Holger Moch (15048065) (author), Erich F. Greiner (15048068) (author), Bernd Bodenmiller (15048071) (author), Luca Regli (15048074) (author), Michael Weller (15037908) (author), Patrick Roth (15048077) (author), Roland Martin (15048080) (author)
出版事項:	2025
主題:	Cancer Immuno-oncology Immunotherapy Cancer vaccines Combination immunotherapy
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Table S4 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
著者:: Jian Wang (15048011)
出版事項: (2025)

Figure S1 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
著者:: Jian Wang (15048011)
出版事項: (2025)

Figure S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
著者:: Jian Wang (15048011)
出版事項: (2025)

Figure S3 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
著者:: Jian Wang (15048011)
出版事項: (2025)

Figure S5 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
著者:: Jian Wang (15048011)
出版事項: (2025)

Figure S6 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
著者:: Jian Wang (15048011)
出版事項: (2025)

Figure S7 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
著者:: Jian Wang (15048011)
出版事項: (2025)

Figure S8 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
著者:: Jian Wang (15048011)
出版事項: (2025)

Table S2 from Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4<sup>+</sup> T-cell Responses in Glioblastoma
著者:: Jian Wang (15048011)
出版事項: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
著者:: Arianna Draghi (15126339)
出版事項: (2025)

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
著者:: Arianna Draghi (15126339)
出版事項: (2025)

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
著者:: Arianna Draghi (15126339)
出版事項: (2025)

Table S2, S4, S5, S6 and S7 from Single-Cell Analysis Reveals a CD4<sup>+</sup> T-cell Cluster That Correlates with PD-1 Blockade Efficacy
著者:: Hiroshi Kagamu (14961732)
出版事項: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8<sup>+</sup> T Cells
著者:: Snehanshu Chowdhury (14957031)
出版事項: (2025)

CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
著者:: Ankita Mitra (17141783)
出版事項: (2025)

Teee Gene Signature DS2 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
著者:: Ankita Mitra (17141783)
出版事項: (2025)

Teee vs Treg Clusters DEGs DS3 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
著者:: Ankita Mitra (17141783)
出版事項: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S7 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S8 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Supplementary Data S1 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
著者:: Maria Lozano-Rabella (15056515)
出版事項: (2025)

Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
著者:: Maria Lozano-Rabella (15056515)
出版事項: (2025)

Supplementary Data S3 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
著者:: Maria Lozano-Rabella (15056515)
出版事項: (2025)

Table S1 from HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden–induced T-cell Exhaustion
著者:: Andrew Nguyen (17142197)
出版事項: (2025)

Image 4_A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2– ORCHESTRA Project.pdf
著者:: Stefano Ugel (7402733)
出版事項: (2025)

UMAP visualizations of extracted CD8<sup> + </sup> T and CD4<sup> + </sup> T cell barcodes, employed for downstream subsequent single-cell trajectory and classification analyses.
著者:: Fatemeh Keikha (20917848)
出版事項: (2025)

Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
著者:: Ibrahim Aldoss (15055961)
出版事項: (2025)

Image 4_Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunization.tif
著者:: Ebony N. Gary (2019478)
出版事項: (2025)

Data Sheet 4_Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunization.pdf
著者:: Ebony N. Gary (2019478)
出版事項: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
著者:: Isha Mondal (16721699)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3dgjuh0834ve0133dal4riq1gj